Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SER

Serina Therapeutics Inc

May 01 • 04:00PM ET

1.82

-0.00 -0.16 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: MRK LLY BMY JNJ AMGN PFE GILD REGN VRTX BIIB

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.89	Insider Own	43.35%	Shs Outstand	10.77M	Perf Week	-7.77%
Market Cap	27.07M	Forward P/E	-	EPS next Y	-1.05	Insider Trans	-2.07%	Shs Float	6.98M	Perf Month	-14.29%
Enterprise Value	32.09M	PEG	-	EPS next Q	-0.44	Inst Own	3.49%	Short Float	5.35%	Perf Quarter	-44.09%
Income	-19.22M	P/S	208.23	EPS this Y	26.18%	Inst Trans	-0.89%	Short Ratio	0.11	Perf Half Y	-61.42%
Sales	0.13M	P/B	-	EPS next Y	25.53%	ROA	-	Short Interest	0.37M	Perf YTD	-5.02%
Book/sh	-0.46	P/C	8.85	EPS next 5Y	22.18%	ROE	-	52W High	7.92 -77.06%	Perf Year	-65.78%
Cash/sh	0.21	P/FCF	-	EPS past 3/5Y	41.84% 28.41%	ROIC	-618.97%	52W Low	1.22 48.93%	Perf 3Y	-90.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 19.21%	Gross Margin	39.23%	Volatility	5.89% 7.80%	Perf 5Y	-96.26%
Dividend TTM	-	EV/Sales	246.85	EPS Y/Y TTM	67.42%	Oper. Margin	-18478.46%	ATR (14)	0.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.71	Sales Y/Y TTM	-	Profit Margin	-14783.85%	RSI (14)	43.80	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.71	EPS Q/Q	-338.80%	SMA20	-7.55%	Beta	1.16	Target Price	11.00
Payout	-	Debt/Eq	-	Sales Q/Q	-100.00%	SMA50	-5.51%	Rel Volume	0.01	Prev Close	1.82
Employees	16	LT Debt/Eq	-	Earnings	Mar 25 AMC	SMA200	-49.22%	Avg Volume	3.33M	Price	1.82
IPO	Nov 29, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	38.00% -	Trades		Volume	23,287	Change	-0.16%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)